News | October 16, 2024
Lupin launches first generic of Pred Forte in US
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
Being the first approved applicant, Lupin is eligible for 180 days of CGT exclusivity
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Subscribe To Our Newsletter & Stay Updated
